InvestorsObserver
×
News Home

Is vTv Therapeutics Inc (VTVT) a Bad Choice in Biotechnology Friday?

Friday, August 12, 2022 03:56 PM | InvestorsObserver Analysts

Mentioned in this article

Is vTv Therapeutics Inc (VTVT) a Bad Choice in Biotechnology Friday?

The 78 rating InvestorsObserver gives to vTv Therapeutics Inc (VTVT) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 92 percent of stocks in the Biotechnology industry, VTVT’s 78 overall rating means the stock scores better than 78 percent of all stocks.

Overall Score - 78
VTVT has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on VTVT!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 78 means the stock is more attractive than 78 percent of stocks.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With vTv Therapeutics Inc Stock Today?

vTv Therapeutics Inc (VTVT) stock is trading at $1.29 as of 3:56 PM on Friday, Aug 12, a gain of $0.04, or 3.2% from the previous closing price of $1.25. The stock has traded between $1.25 and $1.33 so far today. Volume today is 303,546 compared to average volume of 365,857. Click Here to get the full Stock Report for vTv Therapeutics Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App